Retatrutide vs SLU-PP-332

Retatrutide wins for:

• Sheer magnitude and speed of fat loss (especially visceral/liver fat)
• Potency per milligram — you get huge results with relatively low dosing (1–12 mg/week)
• Human clinical data, established protocols, and predictable side effect profile
• Sustainable, programmable appetite suppression (diet compliance weapon)
• Once-weekly injection, easier for most to stick with

SLU-PP-332 wins for:

• Preserving and even enhancing endurance capacity — no performance hit, unlike GLP-1 class
• Avoiding GI and satiety-related side effects (no nausea, no slowed gastric emptying, no appetite crash)
• Orally bioavailable, daily capsule/suspension, no needles required
• True "metabolic rewiring"—cranking up fat oxidation and mitochondrial genes like a hard cardio block, without a stim or CNS load
• Stacks extremely well with other agents for synergistic fat loss, with minimal overlap in side effect mechanism

Pick Retatrutide if:

• You need rapid, clinically-proven fat loss (including stubborn visceral or liver fat)
• Appetite suppression and caloric control are your limiting factors
• Rebounding off a blast or oral-heavy phase, and want to strip off gained fat while preserving lean mass
• You want established titration schedules and human data to guide dosing
• You don't mind weekly injections and want a set-and-forget protocol

Pick SLU-PP-332 if:

• You want to boost fat burning and mitochondrial capacity without touching appetite or satiety
• You want something oral with no GI/nausea sides and virtually no impact on training drive
• You're stacking for a non-stimulant, non-CNS fat-loss regimen (with cardarine, MOTS-c, etc.)
• You have hit a plateau on conventional agents (GLP-1, AICAR, DNP) and want off-label/experimental
• You're hyper-sensitive to the side effects of the GLP-1 class or have contraindications